115 related articles for article (PubMed ID: 37696385)
21. High Expression of
Wang X; Bi Y; Liu X; Liu L; Hao M; Tian M; Shang J
Cancer Biother Radiopharm; 2022 May; 37(4):313-323. PubMed ID: 34388030
[No Abstract] [Full Text] [Related]
22. MicroRNA-203 restrains epithelial-mesenchymal transition, invasion and migration of papillary thyroid cancer by downregulating AKT3.
You A; Fu L; Li Y; Li X; You B
Cell Cycle; 2020 May; 19(10):1105-1121. PubMed ID: 32308106
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of TRIM26 suppresses the proliferation, metastasis, and glycolysis in papillary thyroid carcinoma cells.
Wang K; Chai L; Qiu Z; Zhang Y; Gao H; Zhang X
J Cell Physiol; 2019 Aug; 234(10):19019-19027. PubMed ID: 30927273
[TBL] [Abstract][Full Text] [Related]
24. miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.
Li R; Liu J; Li Q; Chen G; Yu X
Tumour Biol; 2016 Mar; 37(3):3987-96. PubMed ID: 26482618
[TBL] [Abstract][Full Text] [Related]
25. MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3.
Fu S; Ma C; Tang X; Ma X; Jing G; Zhao N; Ran J
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34486645
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
[TBL] [Abstract][Full Text] [Related]
28. TSPYL2 is a novel regulator of SIRT1 and p300 activity in response to DNA damage.
Magni M; Buscemi G; Maita L; Peng L; Chan SY; Montecucco A; Delia D; Zannini L
Cell Death Differ; 2019 May; 26(5):918-931. PubMed ID: 30050056
[TBL] [Abstract][Full Text] [Related]
29. miR-451a suppresses papillary thyroid cancer cell proliferation and invasion and facilitates apoptosis through targeting DCBLD2 and AKT1.
Tan J; Li C; Ren L; Zhu X; Hua F; Fu Y
Mol Cell Probes; 2022 Dec; 66():101863. PubMed ID: 36252912
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-1271 inhibits the progression of papillary thyroid carcinoma by targeting IRS1 and inactivating AKT pathway.
Chen Y; Hao SA; Jiang Y; Gao B; Tian WG; Zhang S; Guo LJ; Wang LL; Luo DL
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7989-7999. PubMed ID: 31599424
[TBL] [Abstract][Full Text] [Related]
31. Function of miR-212 as a tumor suppressor in thyroid cancer by targeting SIRT1.
Li D; Bai L; Wang T; Xie Q; Chen M; Fu Y; Wen Q
Oncol Rep; 2018 Feb; 39(2):695-702. PubMed ID: 29207181
[TBL] [Abstract][Full Text] [Related]
32. TAGLN2 promotes papillary thyroid carcinoma invasion via the Rap1/PI3K/AKT axis.
Wang L; Tan H; Huang Y; Guo M; Dong Y; Liu C; Zhao H; Liu Z
Endocr Relat Cancer; 2023 Jan; 30(1):. PubMed ID: 36222755
[TBL] [Abstract][Full Text] [Related]
33. Cell migration inducing hyaluronidase 1 promotes growth and metastasis of papillary thyroid carcinoma.
Zhou M; Hua W; Sun Y
Bioengineered; 2022 May; 13(5):11822-11831. PubMed ID: 35543351
[TBL] [Abstract][Full Text] [Related]
34. Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway.
Fu J; Lv H; Guan H; Ma X; Ji M; He N; Shi B; Hou P
BMC Cancer; 2013 Oct; 13():462. PubMed ID: 24098937
[TBL] [Abstract][Full Text] [Related]
35. Lysophosphatidic Acid Receptor 5 (LPAR5) Plays a Significance Role in Papillary Thyroid Cancer via Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (mTOR) Pathway.
Wu CY; Zheng C; Xia EJ; Quan RD; Hu J; Zhang XH; Hao RT
Med Sci Monit; 2020 Jan; 26():e919820. PubMed ID: 31902939
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.
Wang Y; Liu BG; Zhou CX
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5863-5873. PubMed ID: 31298337
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA‑497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3.
Zhuang J; Ye Y; Wang G; Ni J; He S; Hu C; Xia W; Lv Z
Mol Med Rep; 2017 Nov; 16(5):5815-5822. PubMed ID: 28849051
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting
Yu C; Zhang L; Luo D; Yan F; Liu J; Shao S; Zhao L; Jin T; Zhao J; Gao L
Thyroid; 2018 Dec; 28(12):1627-1641. PubMed ID: 30244634
[No Abstract] [Full Text] [Related]
39. BGL3 inhibits papillary thyroid carcinoma progression via regulating PTEN stability.
Zhao M; Yang F; Sang C; Yan C; Wang Z
J Endocrinol Invest; 2021 Oct; 44(10):2165-2174. PubMed ID: 33543443
[TBL] [Abstract][Full Text] [Related]
40. Ribonucleotide reductase large subunit M1 plays a different role in the invasion and metastasis of papillary thyroid carcinoma and undifferentiated thyroid carcinoma.
Fang Z; Song R; Gong C; Zhang X; Ren G; Li J; Chen Y; Qiu L; Mei L; Zhang R; Xiang X; Chen X; Shao J
Tumour Biol; 2016 Mar; 37(3):3515-26. PubMed ID: 26453115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
